MET Exon 14 Alterations in Lung Cancer: Exon Skipping Extends Half-Life. - Abstract - Europe PMC
PDF] MET Exon 14 Alterations in Lung Cancer: Exon Skipping Extends Half-Life | Semantic Scholar
Tepotinib in Non–Small-Cell Lung Cancer with MET Exon 14 Skipping Mutations | NEJM
PLOS ONE: MET exon 14 skipping mutations and gene amplification in a Taiwanese lung cancer population
Tepotinib in Non–Small-Cell Lung Cancer with MET Exon 14 Skipping Mutations | NEJM
The design and performance of MET exon 14 skipping mutation qPCR... | Download Scientific Diagram
cMET Exon 14 Skipping: From the Structure to the Clinic - ScienceDirect
MET Mutation Associated with Responsiveness to Crizotinib. - Abstract - Europe PMC
Highly accurate DNA-based detection and treatment results of MET exon 14 skipping mutations in lung cancer - Lung Cancer
MET Exon 14 Skipping Mutations in Lung Adenocarcinoma: Clinicopathologic Implications and Prognostic Values - Journal of Thoracic Oncology
The race to target MET exon 14 skipping alterations in non-small cell lung cancer: The Why, the How, the Who, the Unknown, and the Inevitable - Lung Cancer
Sensitivity and Resistance of MET Exon 14 Mutations in Lung Cancer to Eight MET Tyrosine Kinase Inhibitors In Vitro - Journal of Thoracic Oncology
Schematic representation of MET mutations that lead to exon 14... | Download Scientific Diagram
MET Exon 14 Skipping Alterations in NSCLC: Current Understanding and Therapeutic Advances - touchONCOLOGY
MET Exon 14 Skipping Alterations in NSCLC: Current Understanding and Therapeutic Advances - touchONCOLOGY
Capmatinib for patients with non-small cell lung cancer with MET exon 14 skipping mutations: A review of preclinical and clinical studies - Cancer Treatment Reviews
Mutations as Predictive Biomarkers for Adenocarcinoma | Oncohema Key
MET Exon 14 Skipping Alterations in NSCLC: Current Understanding and Therapeutic Advances - touchONCOLOGY
Optimization of Routine Testing for MET Exon 14 Splice Site Mutations in NSCLC Patients - Journal of Thoracic Oncology
Locations of MET exon 14 genomic alterations found in sarcomatoid... | Download Scientific Diagram
Molecular Diagnostic Assays and Clinicopathologic Implications of MET Exon 14 Skipping Mutation in Non–small-cell Lung Cancer - Clinical Lung Cancer
Incidence and PD-L1 Expression of MET 14 Skipping in Chinese Populatio | OTT
Diagnosis and Discussion -- Case 1068
Lung cancer with MET exon 14 skipping mutation | LCTT
The promise of selective MET inhibitors in non-small cell lung cancer with MET exon 14 skipping - Cancer Treatment Reviews